Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-30

Clinical Trial Update: Clinical Trial of Vildagliptin in Early Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial is evaluating vildagliptin for early Parkinson's disease, with the study listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vildagliptin (vildagliptin)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Parkinson's Disease | NA | Status: NOT_YET_RECRUITING